J.J. Boffa

523 total citations
21 papers, 239 citations indexed

About

J.J. Boffa is a scholar working on Nephrology, Rheumatology and Hematology. According to data from OpenAlex, J.J. Boffa has authored 21 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 6 papers in Rheumatology and 6 papers in Hematology. Recurrent topics in J.J. Boffa's work include Renal Diseases and Glomerulopathies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). J.J. Boffa is often cited by papers focused on Renal Diseases and Glomerulopathies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). J.J. Boffa collaborates with scholars based in France, Russia and Switzerland. J.J. Boffa's co-authors include Jérôme Rossert, Bruno Fouqueray, Éric Daugas, Évangéline Pillebout, Michel Delahousse, Lionel Galicier, L.H. Noël, Khalil El Karoui, Philippe Rémy and Vincent Vuiblet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Medicine.

In The Last Decade

J.J. Boffa

15 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.J. Boffa France 10 102 85 61 55 44 21 239
Smaragdi Marinaki Greece 9 117 1.1× 49 0.6× 17 0.3× 28 0.5× 103 2.3× 45 268
Bogdan Sorohan Romania 11 173 1.7× 104 1.2× 50 0.8× 15 0.3× 46 1.0× 45 351
Barbara Bułło‐Piontecka Poland 9 68 0.7× 66 0.8× 54 0.9× 21 0.4× 31 0.7× 31 248
Hiroyuki Inoshita Japan 12 173 1.7× 76 0.9× 61 1.0× 12 0.2× 36 0.8× 27 310
Marina Foramitti Italy 8 169 1.7× 39 0.5× 28 0.5× 22 0.4× 40 0.9× 9 242
Sevgi Gurkan United States 7 104 1.0× 19 0.2× 97 1.6× 26 0.5× 32 0.7× 8 355
Rocío V. Gamboa‐Cárdenas Peru 12 33 0.3× 271 3.2× 33 0.5× 22 0.4× 30 0.7× 44 351
A. Séchet France 8 175 1.7× 27 0.3× 40 0.7× 28 0.5× 136 3.1× 13 296
Lone Troelsen Denmark 11 29 0.3× 97 1.1× 23 0.4× 40 0.7× 83 1.9× 19 479
David Hooke Australia 6 210 2.1× 61 0.7× 41 0.7× 19 0.3× 48 1.1× 7 389

Countries citing papers authored by J.J. Boffa

Since Specialization
Citations

This map shows the geographic impact of J.J. Boffa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Boffa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Boffa more than expected).

Fields of papers citing papers by J.J. Boffa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Boffa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Boffa. The network helps show where J.J. Boffa may publish in the future.

Co-authorship network of co-authors of J.J. Boffa

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Boffa. A scholar is included among the top collaborators of J.J. Boffa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Boffa. J.J. Boffa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Knebelmann, Bertrand, Kate Bramham, Kieran McCafferty, et al.. (2023). #2528 APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE. Nephrology Dialysis Transplantation. 38(Supplement_1).
3.
Laurent, Charlotte, Laure Ricard, Yann Nguyen, et al.. (2023). Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study. RMD Open. 9(1). e002534–e002534. 11 indexed citations
4.
Guédon, Alexis F., Laure Ricard, Charlotte Laurent, et al.. (2023). Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study. RMD Open. 9(1). e002881–e002881. 6 indexed citations
5.
Guédon, Alexis F., Laure Ricard, Charlotte Laurent, et al.. (2022). Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study. Arthritis Research & Therapy. 24(1). 33–33. 15 indexed citations
6.
Estève, Emmanuel, David Buob, Noémie Abisror, et al.. (2022). Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management. Autoimmunity Reviews. 21(5). 103072–103072. 19 indexed citations
7.
Dahan, Karine, et al.. (2022). Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome. SHILAP Revista de lepidopterología. 6(4). e299–e303. 9 indexed citations
8.
Ricard, Laure, Charlotte Laurent, Matthias Papo, et al.. (2021). Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study. Joint Bone Spine. 89(2). 105297–105297. 6 indexed citations
9.
Michel, P.A., et al.. (2019). L’amélioration de la qualité en hémodialyse quotidienne est précoce et se maintient dans le temps. Néphrologie & Thérapeutique. 15(5). 268–268.
10.
11.
Georgin‐Lavialle, Sophie, K. Stankovic, A. Mékinian, et al.. (2016). Amylose AA secondaire à la fièvre méditerranéenne familiale : à propos de 38 cas. La Revue de Médecine Interne. 37. A119–A120.
12.
Vidal‐Petiot, Emmanuelle, Marie Metzger, J.J. Boffa, et al.. (2016). Déterminants de l’hypertension artérielle au cours de la maladie rénale chronique : résultats de la cohorte Nephrotest. Néphrologie & Thérapeutique. 12(5). 378–379.
13.
Bender, Sébastien, Bettina Fabiani, David Buob, et al.. (2015). Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain. Medicine. 94(32). e1247–e1247. 11 indexed citations
14.
15.
Duquesne, Alyette, Bettina Fabiani, Alexandre Denoyer, et al.. (2013). Complete remission of monoclonal gammopathy with ocular and periorbital crystal storing histiocytosis and Fanconi syndrome. Human Pathology. 44(5). 927–933. 19 indexed citations
16.
Stehlé, Thomas, J.J. Boffa, Philippe Lang, et al.. (2012). Atteintes rénales de la sarcoïdose. La Revue de Médecine Interne. 34(9). 538–544. 12 indexed citations
17.
Karoui, Khalil El, Vincent Vuiblet, Hassane Izzedine, et al.. (2010). Renal involvement in Castleman disease. Nephrology Dialysis Transplantation. 26(2). 599–609. 71 indexed citations
18.
Rossert, Jérôme, Bruno Fouqueray, & J.J. Boffa. (2003). Anemia Management and the Delay of Chronic Renal Failure Progression. Journal of the American Society of Nephrology. 14(suppl_2). S173–S177. 44 indexed citations
19.
Boffa, J.J., et al.. (2000). [Acute renal failure after amoxicillin crystallization].. PubMed. 29(13). 699–701. 12 indexed citations
20.
Boffa, J.J.. (1994). Beta-2 microglobulin as a marker for HIV infection.. PubMed. 26(1). 14–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Smaragdi Marinaki Breakdown of academic impact, for papers by Bogdan Sorohan Breakdown of academic impact, for papers by Barbara Bułło‐Piontecka Breakdown of academic impact, for papers by Hiroyuki Inoshita Breakdown of academic impact, for papers by Marina Foramitti Breakdown of academic impact, for papers by Sevgi Gurkan Breakdown of academic impact, for papers by Rocío V. Gamboa‐Cárdenas Breakdown of academic impact, for papers by A. Séchet Breakdown of academic impact, for papers by Lone Troelsen Breakdown of academic impact, for papers by David Hooke
Rankless by CCL
2026